Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study
Crossref DOI link: https://doi.org/10.1007/s40273-015-0366-8
Published Online: 2016-01-06
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Coyle, Kathryn
Coyle, Doug
Blouin, Julie
Lee, Karen
Jabr, Mohammed F.
Tran, Khai
Mielniczuk, Lisa
Swiston, John
Innes, Mike
Funding for this research was provided by:
Canadian Agency for Drugs and Technology in Health (CADTH)
License valid from 2016-01-06